Aussie/Kiwi M&A/Events

Aussie/Kiwi M&A/Events

Apiam Animal Health (AHX AU): Adamantem's NBIO

Quiddity Research's avatar
Quiddity Research
Aug 19, 2025
∙ Paid
Share
  • Apiam Animal Health (AHX AU), Australia's largest rural and regional veterinary group, has announced a non-binding indicative Offer from PE outfit Adamantem Capital.

  • Adamantem is offering A$0.88/share, a 64.5% premium to last close. If terms are firmed, shareholders will also be afforded a partial scrip option into an unlisted bidco.

  • Adamantem has also entered into a call option for 19.9% of shares out at A$0.88/share. An independent board committee are assessing the approach. Due diligence not yet granted.

Apiam is super illiquid - look away now if that is not your thing.


Conclusions First

  • The call option is with Chris Richards, founder and major shareholder.

    • The call option leaves Richard with ~4.3%.

    • Richards stepped down as CEO on the 5th June 2025.

  • Other key shareholders include Woolworths Ltd (WOW AU) (via its 2022 acquisition of PETstock in 2022, 11.5%); Vita Pepe (recently appointed NED) and Dixon Hospitality.

Keep reading with a 7-day free trial

Subscribe to Aussie/Kiwi M&A/Events to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Quiddity Investment Advisors
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture